Compare AOUT & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOUT | CRDL |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.1M | 97.3M |
| IPO Year | N/A | N/A |
| Metric | AOUT | CRDL |
|---|---|---|
| Price | $7.79 | $1.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $14.00 | $9.00 |
| AVG Volume (30 Days) | 99.8K | ★ 691.7K |
| Earning Date | 12-09-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $207,348,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.08 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.85 | N/A |
| 52 Week Low | $6.26 | $0.77 |
| 52 Week High | $17.91 | $1.59 |
| Indicator | AOUT | CRDL |
|---|---|---|
| Relative Strength Index (RSI) | 61.38 | 48.79 |
| Support Level | $7.61 | $0.88 |
| Resistance Level | $8.16 | $1.12 |
| Average True Range (ATR) | 0.39 | 0.08 |
| MACD | 0.13 | 0.01 |
| Stochastic Oscillator | 70.53 | 60.42 |
American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.